Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
57.9M
-
Shares change
-
+1.97M
-
Total reported value, excl. options
-
$2.62B
-
Value change
-
+$63.3M
-
Put/Call ratio
-
1.99
-
Number of buys
-
83
-
Number of sells
-
-61
-
Price
-
$45.30
Significant Holders of Apogee Therapeutics, Inc. - Common Stock (APGE) as of Q4 2024
186 filings reported holding APGE - Apogee Therapeutics, Inc. - Common Stock as of Q4 2024.
Apogee Therapeutics, Inc. - Common Stock (APGE) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.9M shares
.
Largest 10 shareholders include VR Adviser, LLC (8.49M shares), FMR LLC (7.5M shares), WELLINGTON MANAGEMENT GROUP LLP (4.52M shares), BlackRock, Inc. (3.04M shares), RTW INVESTMENTS, LP (2.71M shares), Driehaus Capital Management LLC (2.61M shares), VANGUARD GROUP INC (2.1M shares), Fairmount Funds Management LLC (2.05M shares), RA CAPITAL MANAGEMENT, L.P. (1.57M shares), and BRAIDWELL LP (1.54M shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.